The Carla Walker Act adds a new Part PP to Title I of the Omnibus Crime Control and Safe Streets Act of 1968 to fund forensic genetic genealogy (FGG) and broad DNA sequencing at the state and local level. It creates two complementary grant lines: one (section 3062) to pay for whole genome sequencing and outsourced analyses where CODIS searches have failed, and another (section 3063) to fund publicly funded labs, coroners, and medical examiners to buy equipment, consumables, and validation expenses needed to deploy FGG techniques.
The bill ties grant activity to the Department of Justice’s November 1, 2019 Interim Policy on forensic genealogical searches, requires detailed recipient reporting and audit access, and authorizes modest annual appropriations. For compliance officers and lab managers this is a targeted federal push to scale FGG capability, change casework workflows, and create new procurement, accreditation, and data‑control obligations — with attendant privacy and vendor‑dependency trade‑offs to evaluate now.
At a Glance
What It Does
The bill authorizes competitive grants for two purposes: (1) pay for whole genome sequencing that assesses at least 100,000 genetic markers and FGG analyses when CODIS yields no lead, and (2) purchase equipment, reagents, and validation resources for publicly funded forensic labs to deploy FGG. It requires grant recipients to follow the DOJ Interim Policy on forensic genealogical DNA analysis, submit annual reports with specific metrics, and permit DOJ audits.
Who It Affects
Eligible recipients include States, tribal and local law enforcement agencies, prosecutors with forensic capabilities, publicly funded accredited forensic laboratories, medical examiners, and coroners; nongovernmental laboratories can be outsourced but must seek accreditation within two years. The Attorney General and DOJ will oversee grant rules, audits, and program reporting.
Why It Matters
The Act actively subsidizes adoption of whole genome sequencing and forensic genetic genealogy in public forensic practice and creates a federal reporting and audit framework around that use. That combination will change case triage (favoring FGG when CODIS fails), increase interactions with private vendors, and sharpen legal and privacy compliance obligations for labs and prosecutors.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Carla Walker Act amends Title I of the Omnibus Crime Control and Safe Streets Act by inserting a new Part PP that creates two grant authorities aimed at expanding forensic genetic genealogy (FGG) capabilities. One grant stream (section 3062) funds the use of technologies in forensic laboratories specifically to run whole genome sequencing that assesses at least 100,000 genetic markers and to ensure compatibility with genealogical databases that law enforcement may use.
That grant is intended for cases where submission to the Combined DNA Index System (CODIS) has failed to generate investigative leads, and for identifying suspected homicide victims from unidentified remains.
Section 3062 lists eligible recipients broadly (States, tribal and local law enforcement, prosecutor labs, medical examiners, coroners), allows recipients to outsource testing to accredited public or private labs, and permits outsourcing to nongovernmental labs that must commit to seek accreditation within two years of their first outsourced request. The provision binds grantees to the Department of Justice’s November 1, 2019 Interim Policy on forensic genealogical DNA analysis for communications and controls, and expressly forbids using these particular grant funds for staffing, training, travel, or equipment (while reserving up to 10 percent for administration by DOJ).The complementary authority (section 3063) narrows eligible recipients to publicly funded accredited forensic laboratories, medical examiners, and coroners and allows those entities to buy equipment, reagents, consumables, and pay validation costs to deploy FGG techniques.
Together the two streams separate funding for analysis (and outsourcing) from funding for capital equipment, creating two different pathways to build capacity. Both streams require standardized applications, and recipients must maintain records and accept audits.Reporting and oversight are central to the package.
Section 3065 requires recipients to report within a year on funding amounts, the number and types of cases tested, labs used for outsourcing, equipment types, identification outcomes (including whether a searchable profile was generated in a publicly available genealogy database), arrests directly resulting from the testing, and average turnaround times. The Attorney General can promulgate regulations, inspect books and records of grantees and their outsourced partners, and must comply with federal suspension and debarment rules.
Finally, the Act requires the Attorney General, in consultation with the NIJ working group, to submit a report to Congress within two years recommending how to implement FGG in public labs, expected funding needs, and necessary regulations.
The Five Things You Need to Know
The bill authorizes two $5,000,000-per-year grant streams (sections 3062 and 3063) for fiscal years 2024–2028 to support forensic genetic genealogy analysis and equipment purchases.
Section 3062 permits grant funds to be used for whole genome sequencing that assesses at least 100,000 genetic markers and requires compatibility with genealogical databases permitted for law enforcement.
Grantees may outsource analyses to accredited public or private labs; nongovernmental labs receiving work must legally commit to seek accreditation within two years of first receiving work.
Section 3062 prohibits using its grant funds for staffing, training, travel, or equipment (while section 3063 separately authorizes equipment purchases, reagents, consumables, and validation costs).
Recipients must report within one year detailed case‑level metrics (number of FGG tests, labs used, equipment, whether a searchable public genealogy profile was created, identification outcomes, arrests, and average days to identification).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions for forensic analysis and laboratory
This section defines 'forensic analysis' as expert testing performed on physical evidence for criminal matters and 'forensic laboratory' as an entity offering such analysis and following chain of custody rules. The definitions anchor later obligations—especially accreditation and evidentiary controls—by emphasizing court‑acceptable procedures and custodial integrity, so recipients and vendors must track chain‑of‑custody practices suitable for admission in court.
Grants to pay for whole genome sequencing and outsourced FGG analyses
Section 3062 establishes a competitive grant available to a broad set of public actors to purchase or pay for the use of technologies that perform whole genome sequencing with at least 100,000 genetic markers and that interface with genealogical databases used by law enforcement. It explicitly targets cases where CODIS failed to produce leads and unidentified human remains. The provision permits outsourcing to accredited vendors and to non‑governmental labs that must legally bind themselves to seek accreditation within two years, and it ties operations to DOJ’s Interim Policy. Critically, the statute bars these analysis grants from subsidizing staffing, training, travel, and equipment, signaling a deliberate split between analysis funding and capital investment.
Grants to purchase equipment and validation resources for FGG
Section 3063 narrows grant eligibility to publicly funded accredited forensic labs and offices of medical examiners and coroners and authorizes funds to buy instruments, supplies, reagents, consumables, and validation expenses required to deploy forensic genetic genealogy. This creates a capital grant that complements the analysis grants in section 3062 and allows public labs to internalize capacity rather than outsource—but only if they meet the eligibility criteria and can access the limited appropriations.
Administration, audits, and outsourcing oversight
This section gives the Attorney General authority to write implementing rules and demands recordkeeping sufficient for DOJ audits. DOJ can access books and records of grantees, the local governments hosting them, and entities to which work is outsourced when those records relate to grant receipt, fund use, or sample/data control as described in DOJ policy. It also requires compliance with federal suspension and debarment rules and permits the AG to use up to 10 percent of appropriations for administration—creating a centralized enforcement path and broad transparency powers over both public and private partners.
Reporting metrics required from grant recipients
Recipients must report within one year on funding amounts, number of FGG tests performed, the types of testing and equipment used, outsourcing partners, identification outcomes including whether tests produced searchable profiles in publicly available genealogy databases, cases leading to arrests, and average days to identification. Those reporting obligations create a quantitative evidence base the DOJ must use to assess program value and to inform later recommendations to Congress.
Attorney General report and implementation recommendations
Within two years of enactment the Attorney General must report to Congress—consulting the NIJ Forensic Laboratory Needs Working Group—on grants awarded and practices, on how best to implement FGG in public labs, expected funding needs, and recommended regulations. The provision institutionalizes executive‑branch review and signals that further regulatory guidance, beyond the 2019 Interim Policy, is expected.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Cold‑case units and homicide investigators — Grants lower the marginal cost of attempting FGG on cases where CODIS failed, increasing the chance of new investigative leads.
- Public forensic laboratories that obtain equipment grants — Accredited labs that win equipment funding can internalize FGG capability, reduce per‑case outsourcing costs, and shorten turnaround times if they invest in validation.
- Medical examiners and coroners — Funding for equipment and analyses improves the ability to identify unidentified human remains and close cases involving suspected homicides.
- Prosecutors and local law enforcement — Those offices gain additional investigative tools and formal reporting requirements that can strengthen case development and document program effectiveness.
- Vendors and private forensic labs — The bill creates predictable market demand for whole genome sequencing and FGG services, including a pathway to work for non‑governmental labs that seek accreditation.
Who Bears the Cost
- Small local jurisdictions without accredited labs — Because section 3062 forbids using analysis grants for staffing or equipment, many small agencies may remain dependent on outsourced vendors or unable to build capacity quickly.
- Nongovernmental laboratories required to seek accreditation — Vendors that accept outsourced work must invest in accreditation processes within two years, creating compliance costs and potential service interruptions.
- Public agencies subject to enhanced audit and reporting requirements — Grantees must maintain detailed records and submit granular reports, imposing administrative and IT burdens on forensic units and offices of coroners/medical examiners.
- Privacy and consumer‑genetics stakeholders — Individuals whose genetic data appear in public genealogy databases may face expanded law enforcement searches without a corresponding federal consent or use framework; civil liberties groups bear the cost of increased oversight needs and litigation pressure.
- Department of Justice (administration and oversight) — DOJ will need to allocate staff and resources (though up to 10 percent of appropriations may be used for administration) to create regulations, run competitive grant processes, conduct audits, and compile the mandated Congressional report.
Key Issues
The Core Tension
The central dilemma is whether to accelerate the use of powerful genomic tools to solve crimes and identify remains — improving investigative outcomes — at the cost of expanding law enforcement access to highly sensitive genomic information, increasing reliance on private vendors, and leaving important privacy and evidentiary limits to administrative policy rather than statute.
The Act pairs funding to run broad whole genome sequencing and genealogy searches with audit and reporting controls, but it leaves several practical implementation questions unresolved. First, the bill defers to the DOJ Interim Policy (2019) or any successor policy, which means substantive rules governing acceptable databases, consent, familial filtering, and profile retention will be set administratively rather than in statute.
That creates legal and procedural variability across time and administrations. Second, the law mandates that nongovernmental labs seeking outsourced work must apply for accreditation within two years, but it does not address transitional safeguards when a vendor is operating prior to accreditation or the evidentiary consequences if accreditation is delayed or denied.
The funding design embeds an operational tension: section 3062 prohibits using analysis grants for staffing, training, or equipment, while section 3063 funds equipment but restricts eligible recipients to publicly funded accredited labs. Smaller law enforcement agencies without accredited lab partners therefore may be steered toward outsourcing—amplifying vendor reliance, chain‑of‑custody complexity, and external control over case timelines.
Finally, the bill requires reporting on whether testing produced searchable profiles in 'publicly available genealogy databases' but does not define that term or address differing database policies and user consent models, which raises unresolved privacy and Fourth Amendment questions and could expose agencies to public backlash or litigation depending on how databases permit law enforcement use.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.